UK markets closed
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • FTSE 250

    22,324.19
    -210.95 (-0.94%)
     
  • AIM

    1,229.80
    -11.57 (-0.93%)
     
  • GBP/EUR

    1.1636
    -0.0053 (-0.46%)
     
  • GBP/USD

    1.3809
    -0.0115 (-0.83%)
     
  • BTC-GBP

    25,813.66
    -1,855.39 (-6.71%)
     
  • CMC Crypto 200

    888.52
    -51.42 (-5.47%)
     
  • S&P 500

    4,166.45
    -55.41 (-1.31%)
     
  • DOW

    33,290.08
    -533.37 (-1.58%)
     
  • CRUDE OIL

    71.50
    +0.46 (+0.65%)
     
  • GOLD FUTURES

    1,763.90
    -10.90 (-0.61%)
     
  • NIKKEI 225

    28,964.08
    -54.25 (-0.19%)
     
  • HANG SENG

    28,801.27
    +242.68 (+0.85%)
     
  • DAX

    15,448.04
    -279.63 (-1.78%)
     
  • CAC 40

    6,569.16
    -97.10 (-1.46%)
     

Global Medical Collagen Market to 2028 - COVID-19 Impact and Analysis

·8-min read

Dublin, May 25, 2021 (GLOBE NEWSWIRE) -- The "Medical Collagen Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Source, Product, and Application" report has been added to ResearchAndMarkets.com's offering.

The medical collagen market is expected to reach 957.4 million by 2028 from US$ 593.7 million in 2020; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028. The growth of the market is mainly attributed to the rising applications of collagen in the medical industry, and increasing number of FDA approvals and product launches. However, product recalls hinder the market growth.

Various players operating in medical collagen market are developing and launching new products to expand their geographic reach and capacity to cater many customers. For instance, in April 2019, Collagen Matrix, Inc., a leading company in regenerative medicine, manufacturing collagen, and mineral based medical devices, received US Food and Drug Administration (FDA) 510(k) approval for its innovative line of OssiMend mineral collagen composite bioactive moldable bone graft matrix.

Further, in 2018, Wright Medical Group N.V. received FDA approval for its AUGMENT Injectable Bone Graft. It consists of recombinant human platelet derived growth factor and a blend of Type-I collagen and beta tri-calcium phosphate.

Similarly, in 2016, the FDA approved Avedro's corneal collagen cross-linking (CXL) to treat keratoconus and other types of corneal ectasia. Constant advancements in products and the approvals of medical collagen products are further driving the growth of the medical collagen market.

Based on application, the medical collagen market is segmented into haemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, bone grafts, diagnostics, and other. The wound care segment held the largest share of the market in 2020, and the bone grafts segment is estimated to register the highest CAGR in the market during the forecast period. A few factors contributing to the market growth for the wound care segment are the increasing prevalence of chronic diseases and conditions affecting wound healing capabilities, growing funds for wound care research, increasing number of road accidents and trauma injuries, and rising use of regenerative medicine in wound management.

The World Health Organization, National Health Service, Centers for Disease Control and Prevention, Organization for Economic Co-operation and Development, National Department of Health, and International Federation of Diabetes along with company websites are among the major primary and secondary sources referred to while preparing the report on the medical collagen market.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the medical collagen market.

  • Highlights key business priorities in order to assist companies to realign their business strategies.

  • The key findings and recommendations highlight crucial progressive industry trends in the global medical collagen market, thereby allowing players across the value chain to develop effective long-term strategies.

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered:

1. Introduction

2. Medical Collagen Market- Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Medical Collagen Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Expert Opinion

5. Medical Collagen Market- Industry Dynamics
5.1 Market Drivers
5.1.1 Rising Applications of Collagen in Medical Industry
5.1.2 Growing FDA Approvals and Product Launches
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Surging Disposable Income and Expanding Middle-Class Population Worldwide
5.4 Future Trends
5.4.1 Increasing Research Activities for Collagen Based Medical Products
5.5 Impact Analysis

6. Medical Collagen Market- Global Analysis
6.1 Global Medical Collagen Market Revenue Forecast and Analysis
6.2 Global Medical Collagen Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Medical Collagen Market Analysis - By Source
7.1 Overview
7.2 Medical Collagen Market Revenue Share, by Source (2020 and 2028)
7.3 Bovine
7.3.1 Overview
7.3.2 Bovine: Medical Collagen Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Porcine
7.4.1 Overview
7.4.2 Porcine: Medical Collagen Market- Revenue and Forecast to 2028 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Medical Collagen Market- Revenue and Forecast to 2028 (US$ Million)

8. Medical Collagen Market Analysis - By Product
8.1 Overview
8.2 Medical Collagen Market Revenue Share, by Product (2020 and 2028)
8.3 Gelatine
8.3.1 Overview
8.3.2 Gelatine: Medical Collagen Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Hydrolysed Collagen
8.4.1 Overview
8.4.2 Hydrolysed Collagen: Medical Collagen Market- Revenue and Forecast to 2028 (US$ Million)
8.5 Native Collagen
8.5.1 Overview
8.5.2 Native Collagen: Medical Collagen Market- Revenue and Forecast to 2028 (US$ Million)
8.6 Other
8.6.1 Overview
8.6.2 Other: Medical Collagen Market- Revenue and Forecast to 2028 (US$ Million)

9. Medical Collagen Market- By Application
9.1 Overview
9.2 Medical collagen Market, by Application, 2020 and 2028 (%)
9.3 Haemostats
9.3.1 Overview
9.3.2 Haemostats: Medical Collagen Market- Revenue and Forecast to 2028 (US$ Million)
9.4 Vascular Grafts
9.4.1 Overview
9.4.2 Vascular Grafts: Medical Collagen Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Tissue Scaffolds
9.5.1 Overview
9.5.2 Tissue Scaffolds: Medical Collagen Market- Revenue and Forecast to 2028 (US$ Million)
9.6 Cartilage Repair
9.6.1 Overview
9.6.2 Cartilage Repair: Medical Collagen Market- Revenue and Forecast to 2028 (US$ Million)
9.7 Wound Care
9.7.1 Overview
9.7.2 Wound Care: Medical Collagen Market- Revenue and Forecast to 2028 (US$ Million)
9.8 Bone Grafts
9.8.1 Overview
9.8.2 Bone Grafts: Medical Collagen Market- Revenue and Forecast to 2028 (US$ Million)
9.9 Diagnostics
9.9.1 Overview
9.9.2 Diagnostics: Medical Collagen Market- Revenue and Forecast to 2028 (US$ Million)
9.10 Others
9.10.1 Overview
9.10.2 Others: Medical Collagen Market- Revenue and Forecast to 2028 (US$ Million)

10. Medical Collagen Market Analysis and Forecasts To 2028 Geographical Analysis
10.1 North America: Medical Collagen Market
10.2 Europe: Medical Collagen Market
10.3 Asia Pacific: Medical Collagen Market
10.4 Middle East & Africa: Medical Collagen Market
10.5 South and Central America: Medical Collagen Market

11. Impact of COVID-19 Pandemic on Global Medical Collagen Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview

13. Company Profiles
13.1 DSM
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Collagen Solutions Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 SYMATESE
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Innocoll Pharmaceuticals
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 ENCOLL Corp.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 CollPlant Biotechnology
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 GELITA AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Collagen Matrix, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Integra Life Sciences Corporation
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Croda International plc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/iyuv5

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting